Headquartered in Teaneck, NJ·Fiscal year ends June·NASDAQ: PAHC·pahc.com
About Phibro Animal Health
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company that serves livestock producers, farmers, veterinarians, and consumers who raise or care for farm and companion animals. The company operates through three segments: Animal Health (including medicated feed additives/MFAs, nutritional specialties, and vaccines), Mineral Nutrition (zinc, copper, and trace minerals for animal feed), and Performance Products (specialty chemicals including copper-based products and ingredients for personal care). Phibro's Animal Health segment, which generates the majority of revenue, offers antimicrobials, nutritional specialty products for dairy and other livestock, and poultry vaccines with particular strength in Latin America and Israel. The company completed a significant MFA portfolio acquisition in October 2024 that expanded its manufacturing footprint and product range. Phibro also operates an ethanol performance business providing antimicrobials and processing aids to the fermentation industry. The company sells its products globally with meaningful operations in North America, Latin America, Israel, and Southeast Asia. Updated
One of Wall Street’s top firms just gave a thumbs-up to Zoetis (NYSE:ZTS | ZTS Price Prediction) stock. Citi initiated coverage with a Buy rating and a $145 price target, naming it…
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company that serves livestock producers, farmers, veterinarians, and consumers who raise or care for farm and companion animals.
What is the PAHC stock price target?
The Wall Street consensus 12-month price target for PAHC is $47.00.